Browse medicines, page 6 of 6
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Showing 301–319 of 319 records
Ustekinumab-Aekn (Selarsdi)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who are candidates for phototherapy or syste
Ustekinumab-Auub (Wezlana)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Hmny (Starjemza)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Stba (Steqeyma)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Ttwe (Pyzchiva)
Protein medicineApproved in the United States (FDA)Expanded recordVeligrotug-Vvze (Lumvoa)
Protein medicineApproved in the United States (FDA)Expanded recordVestronidase Alfa-Vjbk (Mepsevii)
Protein medicineApproved in the United States (FDA)Expanded recordZanidatamab-Hrii (Ziihera)
Protein medicineApproved in the United States (FDA)Expanded recordZenocutuzumab-Zbco (Bizengri)
Protein medicineApproved in the United States (FDA)Expanded recordRanibizumab-Leyk (Nufymco)
Protein medicineApproved in the United States (FDA)Expanded recordRisankizumab-Rzaa (Skyrizi)
Protein medicineApproved in the United States (FDA)Expanded recordTagraxofusp-Erzs (Elzonris)
Protein medicineApproved in the United States (FDA)Expanded recordTividenofusp Alfa-Eknm (Avlayah)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab-Qyyp (Trazimera)
Protein medicineApproved in the United States (FDA)Expanded recordTremelimumab-Actl (Imjudo)
Protein medicineApproved in the United States (FDA)Expanded recordRituximab-Arrx (Riabni)
Protein medicineApproved in the United States (FDA)Expanded recordSotatercept-Csrk (Winrevair)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Pulmonary arterial hypertension (PAH, Group 1 pulmonary hypertension) to improve exercise capacity and World Health Organization
Thyrotropin alfa (Thyrogen)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
THYROGEN ® is a thyroid stimulating hormone indicated for: Adjunctive Diagnostic Tool for Well-Differentiated Thyroid Cancer: Use as an adjunctive diagnostic tool for serum thyroglobulin (Tg) testing with or without radioiodine imaging in the follow-up of patients with well-differentiated thyroid cancer who have previously undergone thyroidectomy. ( 1.1 ) Limitations of Use : THYROGEN-stimulated Tg levels are generally lower than, and do not correlate with Tg levels after thyroid hormone withdrawal.
Toripalimab-Tpzi (Loqtorzi)
Protein medicineApproved in the United States (FDA)Expanded record